Comparison of outcomes after transplantation of g-csf-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from hla-matched sibling donors for patients with severe aplastic anemia

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 7, 2011, Pages 1018-1024

  Chu, Roland ^a   Brazauskas, Ruta ^b   Kan, Fangyu ^c   Bashey, Asad ^d   Bredeson, Christopher ^b   Camitta, Bruce ^b   Chiang, Kuang Yueh ^e   Frangoul, Haydar ^f   Gale, Robert Peter ^g   Gee, Adrian ^h   George, Biju ⁱ   Goldman, Frederick D ^j   Gross, Thomas G ^k   Gupta, Vikas ^l   Hale, Gregory A ^m   Isola, Luis ⁿ   Ispizua, Alvaro Urbano ^o   Lazarus, Hillard ^p   Marsh, Judith ^q   Russell, James ^r   Sabloff, Mitchell ^s   Waller, Edmund K ^o   Eapen, Mary ^l   more..

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c NATIONAL MARROW DONOR PROGRAM   (United States)

^d Blood and Marrow Transplant Group of Georgia   (United States)

^e EMORY UNIVERSITY   (United States)

^f VANDERBILT UNIVERSITY   (United States)

^g CELGENE CORPORATION   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ CHRISTIAN MEDICAL COLLEGE   (India)

^j CHILDREN S HOSPITAL OF ALABAMA   (United States)

^k NATIONWIDE CHILDREN S HOSPITAL   (United States)

^l PRINCESS MARGARET HOSPITAL   (Canada)

^m JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

ⁿ MOUNT SINAI MEDICAL CENTER   (United States)

^o HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^p CASE WESTERN RESERVE UNIVERSITY   (United States)

^q KING S COLLEGE HOSPITAL   (United Kingdom)

^r UNIVERSITY OF CALGARY   (Canada)

^s UNIVERSITY OF OTTAWA   (Canada)

more..

Author keywords

Aplastic anemia; G mobilized BM; GVHD; Survival

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; COMPARATIVE STUDY; DONOR; FEMALE; GRAFT RECIPIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL COUNT; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RISK FACTOR; SCHOOL CHILD; SEVERE APLASTIC ANEMIA; SIBLING; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; BONE MARROW; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; LEUKOCYTE COUNT; LIVING DONORS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RETROSPECTIVE STUDIES; SIBLINGS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958756704     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.10.029     Document Type: Article

References (20)

1. Bensinger W.I., Martin P.J., Storer B., et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001, 344:175-181.
2. Storek J., Gooley T., Siadak M., et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997, 90:4705-4709.
3. Brown R.A., Adkins D., Khoury H., et al. Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality. J Clin Oncol 1999, 17:806-812.
4. Champlin R.E., Schmitz N., Horowitz M.M., et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000, 95:3702-3709.
5. Flowers M.E., Parker P.M., Johnston L.J., et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002, 100:415-419.
6. Eapen M., Logan B.R., Confer D.L., et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 2007, 13:1461-1468.
7. Damiani D., Grimaz S., Infanti L., et al. Autologous bone marrow transplantation in non-Hodgkin's lymphoma patients: effect of a brief course of G-CSF on harvest and recovery. Bone Marrow Transplant 1999, 24:757-761.
8. Isola L.M., Scigliano E., Skerrett D., et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant 1997, 20:1033-1037.
9. Couban S., Messner H.A., Andreou P., et al. Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients. Biol Blood Marrow Transplant 2000, 6:422-427.
10. Morton J., Hutchins C., Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 2001, 98:3186-3191.
11. Serody J.S., Sparks S.D., Lin Y., et al. Comparison of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant 2000, 6:434-440.
12. Schrezenmeier H., Passweg J.R., Marsh J.C., et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood 2007, 110:1397-1400.
13. Camitta B.M., Thomas E.D., Nathan D.G., et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic Anemia. Blood 1979, 53:504-514.
14. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
15. Atkinson K., Horowitz M.M., Gale R.P., et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990, 75:2459-2464.
16. Klein J.P., Moeschberger M.L. Survival Analysis: Techniques of Censored and Truncated Data 2003, Springer, New York.
17. Eapen M., Horowitz M.M., Klein J.P., et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 2004, 22:4872-4880.
18. Schmitz N., Eapen M., Horowitz M.M., et al. Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 2006, 108:4288-4290.
19. Chiang K.Y., Lamb L., Clark J., Worthington-White D., Rich I., Henslee-Downey P.J. Assessment of G-CSF stimulated BM hematopoietic stem cells in normal donors. Cytotherapy 2002, 4:55-63.
20. Martinez C., Urbano-Ispizua A., Rozman M., et al. Effects of short-term administration of G-CSF (filgrastim) on bone marrow progenitor cells: analysis of serial marrow samples from normal donors. Bone Marrow Transplant 1999, 23:15-19.